THUY DO: Open Payments
NPI 1124336797 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 28 payments from 14 companies in 2025. Trend: 2023 $362 · 2024 $267 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $178 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| GlaxoSmithKline, LLC. | 1 | $93 |
| Kowa Pharmaceuticals America, Inc. | 4 | $79 |
| Edwards Lifesciences Corporation | 2 | $58 |
| Exact Sciences Corporation | 2 | $55 |
| SANOFI-AVENTIS U.S. LLC | 2 | $49 |
| Lilly USA, LLC | 1 | $33 |
| Novo Nordisk Inc | 1 | $30 |
| PFIZER INC. | 1 | $25 |
Products named: Kerendia, FARXIGA, AREXVY, ZORYVE, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), The Cologuard Plus Collection Kit, TZIELD, MOUNJARO.
Industry payments across WA — which companies pay providers there.
